GO
Loading...

Pharmaceuticals

More

  • WASHINGTON— Obama:' Eyes of the world on eastern Ukraine; We're going to make sure that truth gets out'.

  • Shire, Abbvie to announce merger shortly?     Friday, 18 Jul 2014 | 4:30 AM ET

    Surani Fernando, assistant editor at Biopharm Insight, says the market sees the latest Abbvie's takeover bid for Shire as fair and that the announcement of a merger should soon be made.

  • BEIJING, July 17- China will publicly prosecute a foreign couple linked to drugmaker GlaxoSmithKline Plc on charges of illegally obtaining private information, state media said. The announcement comes after the United States and Britain raised concerns about access to the trial.

  • UPDATE 2-Gambro acquisition boosts Baxter's sales Thursday, 17 Jul 2014 | 1:30 PM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.

  • July 17- Shire Plc and U.S. drugmaker Abbvie Inc plan to announce a $53 billion merger as soon as Friday morning, two people said on Thursday. Dublin- based Shire, which sells drugs for rare diseases, said earlier this week it was ready to recommend a deal to shareholders after AbbVie increased its offer.

  • July 17- Shire Plc and U.S. drugmaker Abbvie Inc plan to announce a $53 billion merger as soon as Friday morning, two people said on Thursday. Dublin- based Shire, which sells drugs for rare diseases, said earlier this week it was ready to recommend a deal to shareholders after AbbVie increased its offer.

  • BEIJING, July 17- China will try in public a foreign couple linked to drugmaker GlaxoSmithKline Plc on charges of illegally obtaining private information, state media said, after the United States and Britain raised concerns about access to the trial.

  • Paying for diabetes pandemic     Thursday, 17 Jul 2014 | 8:49 AM ET

    Lars Sorensen, Novo Nordisk CEO, explains why the Affordable Care Act isn't affordable for people with diabetes.

  • UPDATE 1-Medical products boost Baxter's sales Thursday, 17 Jul 2014 | 8:33 AM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly earnings and revenue, helped by surging sales in its medical products division. Net adjusted income rose to $692 million, or $1.26 per share in the second quarter ended June 30, from $639 million, or $1.16 per share, a year earlier.

  • ZURICH, July 17- Swiss drugmaker Novartis posted a quarterly rise in sales that missed expectations and said it would focus on eking out gradual cost savings to boost margins as it prepares a radical business overhaul.

  • Novartis cites momentum in 3 percent profit rise Thursday, 17 Jul 2014 | 2:07 AM ET

    GENEVA— Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products.

  • The billionaire investors, who have been at odds over nutrition and diet company Herbalife, made up in public on Wednesday, ending a decade long feud that exploded on cable television 18 months ago.

  • Studies see new risks for cholesterol drug niacin Wednesday, 16 Jul 2014 | 5:10 PM ET

    New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use. Those details are in this week's New England Journal of Medicine.

  • NEW YORK, July 16- Billionaire investor John Paulson on Wednesday called Valeant Pharmaceuticals International Inc a "very serious acquirer" and predicted that Allergan Inc cannot rebuff the drug maker on its own.

  • *Three ex-GSK staff seek labour arbitration in Shanghai. BEIJING/ SHANGHAI, July 16- Three former Chinese employees of GlaxoSmithKline PLC, which is embroiled in a long-running corruption probe in China, are seeking compensation for illegal dismissal from their jobs, a lawyer representing them told Reuters.

  • Abbott 2Q profit falls on higher taxes, revenue up Wednesday, 16 Jul 2014 | 9:22 AM ET

    The generic drugmaker Mylan Inc. announced this week that it is buying Abbott's generic-drugs business in developed markets for stock valued at about $5.3 billion. For the period ended June 30, Abbott— which makes infant formula like Similac as well as medical devices and drugs— earned $466 million, or 30 cents per share.

  • *Sanofi mulls fate of 200 older drugs including Plavix. *Sanofi also held talks with TPG and Warburg Pincus. PARIS, July 16- Sanofi has held talks with Abbott Laboratories, Mylan and private equity firms over the possible sale of a 6.3 billion euro portfolio of mature drugs, according to an internal document seen by Reuters.

  • Sanofi mulls selling mature drug portfolio: Report Wednesday, 16 Jul 2014 | 8:39 AM ET

    Sanofi talked with Abbott Laboratories, Mylan and private equity firms over selling a portfolio of mature drugs, according to a document.

  • *Three ex-GSK staff seek labour arbitration in Shanghai. BEIJING/ SHANGHAI, July 16- Three former Chinese employees of GlaxoSmithKline PLC, which is embroiled in a long-running corruption probe in China, are seeking compensation for illegal dismissal from their jobs, a lawyer representing them told Reuters.

  • Next global epidemic?     Tuesday, 15 Jul 2014 | 1:40 PM ET

    CNBC's Meg Tirrell reports which biotech companies are working on what analysts say could be the next big biotech catalyst known as NASH, or nonalcoholic steatohepatitis.